Q4 2024 Earnings Call Transcript March 6, 2025 Atea Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is ...

You can access the press release as well as the slides that we'll be reviewing today ... And let's not forget that in the United States, 70% of liver cancer is a consequence of HCV disease ...

Discover the 5 ways alcohol progressively harms your liver, from early warning signs to serious complications, plus expert ...

Acute kidney injury (AKI) is estimated to occur in up to 50% of patients with liver cirrhosis and is associated with increased morbidity and a high risk of short-term and long-term mortality.1 ...

Liver fibrosis is a major global health concern, developing as a result of chronic liver diseases (CLDs) such as viral ...

Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic fatty liver diseases (NAFLD) into more severe forms of liver disease by ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease that progresses without symptoms and is associated with significant global public health concerns.

Scientists have uncovered how ammonia wreaks havoc on liver cells by damaging mitochondria, leading to a dangerous cycle of toxicity. This discovery provides new hope as an existing drug, YAQ-005, ...

Weight-Loss Surgery Lowers Risk of Developing Complications of Liver Disease in Patients With Cirrhosis and Obesity Jan. 27, 2025 — A study shows that patients with obesity and fatty liver ...

The number one unmet need is that we don't have a good handle on who's at risk, because patients generally don't have too ...

Good afternoon, everybody and welcome to Atea Pharmaceuticals fourth-quarter 2024 financial results and business update conference call. (Operator Instructions) I would now like to hand the call over ...